The notices it replaced
Its page was not saved, so the notices it replaced are not known.
Who won it before
4 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $1,055,265 in first-year total cost, median $237,724.
Most frequent study sections
- Cancer Prevention Study Section[CPSS]1
- Mechanisms of Cancer Therapeutics C Study Section [MCTC]1
- Special Emphasis Panel[ZRG1 TIO-D (01)]1
- Therapeutic Immune Regulation Study Section[TIR]1
Most frequent institutions
- HARVARD MEDICAL SCHOOL1
- STANFORD UNIVERSITY1
- UNIV OF NORTH CAROLINA CHAPEL HILL1
- WEILL MEDICAL COLL OF CORNELL UNIV1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2025 | Discovering Fusobacterium nucleatum's Impact on Breast Cancer Progression and Treatment with POx Micelle Technology1R21CA305031-01 | KABANOV, ALEXANDER V | UNIV OF NORTH CAROLINA CHAPEL HILL, NC | $399,829 | MCTC |
| 2025 | Modulating Human Microbiome Function to Enhance Immune Responses Against Cancer1R21CA290426-01A1 | SONNENBURG, JUSTIN L | STANFORD UNIVERSITY, CA | $179,988 | TIR |
| 2024 | Tetraacylated lipid A enhancement of checkpoint blocking cancer immunotherapy1R21CA287104-01 | KASPER, DENNIS L. | HARVARD MEDICAL SCHOOL, MA | $237,724 | ZRG1 |
| 2023 | Dissecting the interplay between immunoglobulin G and the gut microbiome in cancer progression and metastasis1R21CA270998-01A1 | MATEI, IRINAZENG, MELODY YZHOU, XI KATHY | WEILL MEDICAL COLL OF CORNELL UNIV, NY | $237,724 | CPSS |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.